Results 141 to 150 of about 19,125 (215)

Tripterygium Glycoside Tablets Combined With Conventional Synthetic Disease-Modifying Antirheumatic Drugs for Treating Rheumatoid Arthritis: Protocol for a Prospective, Multicenter, Open-Label Randomized Controlled Trial. [PDF]

JMIR Res Protoc
Lv L, Wang T, Lv J, Liu C, Zhao L, Zhou Y.   +5 more
europepmc   +1 more source

Incidence of interstitial lung disease in seropositive rheumatoid arthritis patients receiving biologics, Janus kinase inhibitors, or methotrexate. [PDF]

Ther Adv Musculoskelet Dis
Yoon J, Han M, Song JJ, Lee SW, Jung I, Park YB.   +5 more
europepmc   +1 more source

Interpretable Machine Learning Framework for Predicting Major Adverse Cardiovascular Events in Rheumatoid Arthritis Using Electronic Health Records: Multicenter Cohort Study. [PDF]

JMIR Form Res
Chiang WC, Lin GL, Chang YS, Liu YC, Huang CW, Nguyen PA, Hsu JC, Liou DM, Yang HC.   +8 more
europepmc   +1 more source

Effects of biologic and targeted synthetic disease modifying antirheumatic drugs (b/tsDMARDs) on patient-reported outcome domains in rheumatoid arthritis: a systematic review and network meta-analyses. [PDF]

RMD Open
van Esveld L, Dikkenberg MVD, Luurssen-Masurel N, de Jong P, Kok MR, Bosch T, Hackert MQN, Weel-Koenders A, Lopes Barreto D, Kuijper TM.   +9 more
europepmc   +1 more source

Angiogenic markers in difficult-to-treat psoriatic arthritis. [PDF]

Front Immunol
Haddad A, Simanovich E, Araide D, Stein N, Hayat N, Milman K, Gazitt T, Feld J, Elias M, Rahat MA, Zisman D.   +10 more
europepmc   +1 more source

Biologics reduced infections in ankylosing spondylitis and psoriatic arthritis under immunosuppressants. [PDF]

J Chin Med Assoc
Tung HY, Liao HT, Wang CC, Chen WL, Tsai CY.   +4 more
europepmc   +1 more source

Small Bowel Perforation as an Initial Manifestation of Immune Deficiency and Dysregulation-Associated Lymphoma in a Patient With Rheumatoid Arthritis: A Case Report. [PDF]

Cureus
Shibata C, Sasaki N, Tada S, Maeda M.
europepmc   +1 more source

Tofacitinib demonstrates favorable efficacy but an increased risk of herpes zoster in elderly patients with rheumatoid arthritis: a retrospective cohort analysis. [PDF]

Am J Transl Res
Wang J, Luo Y, Wang S.
europepmc   +1 more source

[Local antirheumatic agents].

Terapevticheskii arkhiv, 1990
openaire   +1 more source

Lower odds of prevalent vertebral fractures with b/tsDMARD use among rheumatoid arthritis patients in clinical remission: a retrospective observational study. [PDF]

Clin Rheumatol
Yamashita Y, Maeda K, Zenitani A, Saito M.   +3 more
europepmc   +1 more source